Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
November 24, 1999
Wide variation in lymphocyte steroid sensitivity among healthy human volunteers
S D Hearing, M Norman, C Smyth, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 18, 2007
Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetes
A J K Williams, W Chau, M P Callaway, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1993
T cells involved in human autoimmune disease are resistant to tolerance induction
C M Dayan, N R Chu, M Londei, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
May 5, 2007
Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy
P Saravanan, H Siddique, D J Simmons, et al.
Gut
|
August 14, 1999
Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes
S D Hearing, M Norman, C S Probert, et al.
Immunology Today
|
May 1, 1993
Determinant spreading and the dynamics of the autoimmune T-cell repertoire
P V Lehmann, E E Sercarz, T Forsthuber, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 18, 2020
Announcing the first AoP webinar: 'Can evidence-based medicine survive in a pandemic?'
C Delles, C M Dayan, A F Dominiczak, et al.
Clinical Endocrinology
|
October 23, 2002
Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study
P Saravanan, W-F Chau, N Roberts, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 19, 2013
Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study
P Ambery, T W Donner, N Biswas, et al.
Annals of Clinical Biochemistry
|
April 30, 2016
Thyroxine replacement: a clinical endocrinologist's viewpoint
V Eligar, P N Taylor, O E Okosieme, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
The Journal of Clinical Endocrinology and Metabolism
|
November 24, 1999
Wide variation in lymphocyte steroid sensitivity among healthy human volunteers
S D Hearing, M Norman, C Smyth, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 18, 2007
Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetes
A J K Williams, W Chau, M P Callaway, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1993
T cells involved in human autoimmune disease are resistant to tolerance induction
C M Dayan, N R Chu, M Londei, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
May 5, 2007
Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy
P Saravanan, H Siddique, D J Simmons, et al.
Gut
|
August 14, 1999
Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes
S D Hearing, M Norman, C S Probert, et al.
Immunology Today
|
May 1, 1993
Determinant spreading and the dynamics of the autoimmune T-cell repertoire
P V Lehmann, E E Sercarz, T Forsthuber, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 18, 2020
Announcing the first AoP webinar: 'Can evidence-based medicine survive in a pandemic?'
C Delles, C M Dayan, A F Dominiczak, et al.
Clinical Endocrinology
|
October 23, 2002
Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study
P Saravanan, W-F Chau, N Roberts, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 19, 2013
Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study
P Ambery, T W Donner, N Biswas, et al.
Annals of Clinical Biochemistry
|
April 30, 2016
Thyroxine replacement: a clinical endocrinologist's viewpoint
V Eligar, P N Taylor, O E Okosieme, et al.
Page
of 7